Business
This company has entered a trading halt, is it about to announce FDA approval?
Image source: Getty Images
Orthocell Ltd (ASX: OCC) is an Australian medical technology company focused on developing and commercialising innovative regenerative medicine treatments.
Over the last 12 months its share price has skyrocketed, up more than 260% in that span.
For context, S&P/ASX…
Continue Reading
-
General22 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
General24 hours agoVulnerable youth non-for-profit Allambi Care agrees to end ‘unacceptable’ housing scheme
-
Noosa News21 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan
-
General20 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park